OR WAIT null SECS
A tidal wave of questions floats the need for more upstream automation.
The milestone approval of a gene-edited therapeutic paves the way for gene-editing technologies.
Both adherent and suspension cell culture approaches have their pros and cons, which must be considered for process development.
April 16, 2024
This investment will bolster the company’s large-scale cell culture CDMO business at its planned Fujifilm Diosynth Biotechnologies manufacturing facility in Holly Springs, North Carolina.
April 02, 2024
Despite a growing trend toward single-use bioreactors, stainless-steel retains its relevance for certain products.
March 02, 2024
February 20, 2024
Challenges in fermentation can be addressed through equipment changes, facility design, and process development.
February 02, 2024
January 22, 2024
Abzena has launched its AbZelect platforms, designed for improving cell line development.
January 02, 2024
The authors give an overview of scaling approaches and present good scaling practices for the biopharma industry.
December 28, 2023
Tome Bioscience is facilitating the transition in biology from the editing phase to the cut-and-paste phase.
November 02, 2023
Re-evaluating the basics of mAb production may be beneficial for the biopharma industry as a whole.